Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287). J of Skin [Internet]. 2025 Jul. 23 [cited 2026 May 1];9(4):s588. Available from: https://skin.dermsquared.com/skin/article/view/3533